KEGG   DRUG: Imlifidase
Entry
D11470                      Drug                                   

Name
Imlifidase (USAN/INN);
Idefirix (TN)
Formula
C1575H2400N422O477S6
Exact mass
35049.484
Mol weight
35070.8397
Sequence
MDSFSANQEI RYSEVTPYHV TSVWTKGVTP PANFTQGEDV FHAPYVANQG WYDITKTFNG
KDDLLCGAAT AGNMLHWWFD QNKDQIKRYL EEHPEKQKIN FNGEQMFDVK EAIDTKNHQL
DSKLFEYFKE KAFPYLSTKH LGVFPDHVID MFINGYRLSL TNHGPTPVKE GSKDPRGGIF
DAVFTRGDQS KLLTSRHDFK EKNLKEISDL IKKELTEGKA LGLSHTYANV RINHVINLWG
ADFDSNGNLK AIYVTDSDSN ASIGMKKYFV GVNSAGKVAI SAKEIKEDNI GAQVLGLFTL
STGQDSWNQT N
  Type
Peptide
Remark
ATC code: L04AA41
Efficacy
Immunosuppressant, Immunoglobulin modulator (enzyme)
Comment
Pre-transplant treatment to make patients with donor specific IgG eligible for kidney transplantation
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L04 IMMUNOSUPPRESSANTS
   L04A IMMUNOSUPPRESSANTS
    L04AA Selective immunosuppressants
     L04AA41 Imlifidase
      D11470  Imlifidase (USAN/INN)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11470
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11470
Other DBs
CAS: 1947415-68-0
PubChem: 384585446
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system